Abstract: Abstract: Since the first discovery of Adropin in the study of insulin resistance in mouse model by Kumar et al in 2008, more and more evidence has been shown that Adropin is closely related to coronary heart disease (CHD). Adropin plays an important role in the development of CHD, which involves in energy metabolism, insulin resistance and vascular endothelial protection. This paper reviews the research progress on the relationship between Adropin and CHD, and provides a reference for the risk prediction and prevention in CHD.

Key words: coronary disease, Adropin, risk prediction, review